Option chain shows key data for InMed Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for InMed Pharmaceuticals.

InMed Pharmaceuticals (NASDAQ:INM) Stock, Option Chain

InMed Pharmaceuticals

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

King,County,,Washington,,United,States,-,30,January,2022:,Netflix

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ANAB

ASST

CCLD

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

DWTX

HSDT

HUBC

LSTA

NEHC

NFLX

SEPN

STFS

USEG

Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Crude-oil-4-logo

Equities

Eurozone

Commodities

New Oriental Education & Technology Group

EOLS

FTAI

GOEV

Crude Oil Down 2%; D.R. Horton Earnings Top Views

doctor-563429

InMed Pharmaceuticals shares are trading higher by 45% during Tuesday&#39;s session. The company announced that INM-901 reduced Alzheimer &#39;s-related inflammation in a preclinical study.

Why InMed Pharmaceuticals (INM) Stock Is Skyrocketing

InMed Pharmaceuticals Inc. - Common Shares

InMed Pharmaceuticals Inc

INmune Bio Inc

InMode Ltd

Inca Minerals Ltd

iShares Intermediate Muni Income Active ETF

InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer's – New Studies Showcase INM-901's Therapeutic Abilities

Press Releases

Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

The Rising Importance Of Minor Cannabinoids In The Growing Edible Market

InMed Demonstrates Encouraging Data For Its Cannabinoid INM-089 In Treating Dry AMD, An Ocular Disease With Rising Patient Numbers As National Population Ages

AAWH

ASPI

ATRA

BIXT

CLNN

CSE:KASH

CSE:TEX

CVKD

DBMM

FBRKF

GTRIF

IMRN

KASHF

LGMK

LGVN

MHUA

PERF

PSRHF

RERE

RGBP

SNES

SUGCF

TRGEF

TSXV:PLSR

TSXV:SUG

UMAC

Screenshot 2024-08-27 at 5.44.40 PM

Biotech

General

Screenshot 2024-07-18 at 5.31.04 PM

Cannabis

Screenshot 2024-05-06 at 5.34.20 PM

InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer&#39;s – New Studies Showcase INM-901&#39;s Therapeutic Abilities

Comments

InMed Pharmaceuticals

InMed Pharmaceuticals (INM) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell